within Pharmacolibrary.Drugs.ATC.C;

model C04AX21
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 60 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,
    adminCount     = 1,
    Vd             = 0.1,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Naftidrofuryl is a vasodilator that acts as a serotonin (5-HT2) receptor antagonist, used primarily for the symptomatic treatment of peripheral vascular diseases such as intermittent claudication. It was marketed in several countries, especially in Europe, but is not widely used or approved for new patients in many countries today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult volunteers following oral administration.</p><h4>References</h4><ol><li><p>Hulot, T, et al., &amp; Bromet, M (1998). Influence of age on the pharmacokinetics of naftidrofuryl after single oral administration in elderly versus young healthy volunteers. <i>Arzneimittel-Forschung</i> 48(9) 900–904. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9793615/&quot;>https://pubmed.ncbi.nlm.nih.gov/9793615</a></p></li><li><p>Barradell, LB, &amp; Brogden, RN (1996). Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease. <i>Drugs &amp; aging</i> 8(4) 299–322. DOI:<a href=&quot;https://doi.org/10.2165/00002512-199608040-00005&quot;>10.2165/00002512-199608040-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8920176/&quot;>https://pubmed.ncbi.nlm.nih.gov/8920176</a></p></li><li><p>Legallicier, B, et al., &amp; Bromet-Petitd, M (2005). Pharmacokinetics of naftidrofuryl in patients with renal impairment. <i>Arzneimittel-Forschung</i> 55(7) 370–375. DOI:<a href=&quot;https://doi.org/10.1055/s-0031-1296874&quot;>10.1055/s-0031-1296874</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16080275/&quot;>https://pubmed.ncbi.nlm.nih.gov/16080275</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C04AX21;
